Following the legalization of adult-use cannabis in Canada and a number of US states, North America is poised to be the largest market for the plant moving forward. According to Arcview Market Research and BDS Analytics, legal cannabis spending in North America could reach as much as US$47.3 billion by 2027.

The projected growth of cannabis spending and investment has seen a response in technical innovations, ranging in applications from cultivation, medicinal and consumer products, payment processing and data analytics. These developments are supporting licensed producers, retailers and cannabis researchers in effectively scaling their operations as the industry continues to expand.


Cannabis cultivation has seen a shift in what it means to run an agricultural operation. In the search for high yield and high-quality product, licensed producers have implemented technological solutions and cultivation techniques like using tissue culture to produce identical clones in a sterile environment.

A more established market than that of adult-use, the medicinal cannabis space has also seen innovations in consumption methods in the form of vaporizer pens and oils and tinctures. Oils and extracts are easily measured, making them for accurate from a dosing perspective. Consumer products have also advanced in number with the likes of nanotechnology formulations and topicals emerging on the scene.

On the retail side, fintech and cashless payment processing solutions are being developed using blockchain technology to protect against fraud and theft. As the market ages, there will also be more and more data to collect and analyze with analytics tools being designed specifically for cannabis producers, retailers, consumers and more.

Spurred by the current state of the market, these innovations will be pivotal in developing the cannabis industry, providing alternative routes for investors to engage with this growing space.

The following Visual Capitalist infographic, sponsored by The Valens Company (CSE:VLNS,OTC:MYMSF), will help investors learn more about the innovations spurring opportunity in the cannabis market:

Infographic courtesy of Visual Capitalist.

Click here for INN’s exclusive profile of The Valens Company. 

This infographic is sponsored by The Valens Company (CSE:VLNS,OTC:MYMSF). This infographic provides information which was sourced by the Investing News Network (INN) and approved by The Valens Company, in order to help investors learn more about the company. The Valens Company is a client of INN. The company’s campaign fees pay for INN to create and update this infographic.

This infographic was created according to INN editorial standards to educate investors.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with The Valens Company and seek advice from a qualified investment advisor.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less